Showing results (321-330 of 336) with videos related to
Sort By:
Pageof 34
The Lancet. Infectious Diseases|December 10, 2021
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trialsGang Zeng, Qianhui Wu, Hongxing Pan, et al.Mabs|February 19, 2015
Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesisLin Cheng, Xian Tang, Li Liu, et al.Food Chemistry: X|November 6, 2023
Soluble sugar and organic acid composition and flavor evaluation of Chinese cherry fruitsJingting Zhou, Shuaiwei Yang, Yan Ma, et al.Plants (Basel, Switzerland)|September 9, 2023
Autotetraploid Origin of Chinese Cherry Revealed by Chromosomal Karyotype and In Situ Hybridization of Seedling ProgeniesYan Wang, Xueou Li, Yan Feng, et al.Frontiers in Immunology|April 4, 2022
Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22)Xilin Wu, Yaxing Wang, Lin Cheng, et al.Proceedings of the National Academy of Sciences of the United States of America|April 28, 2025
A symbiotic gene stimulates aggressive behavior favoring the survival of parasitized caterpillarsZhiwei Wu, Xiaotong Wu, Zhizhi Wang, et al.CNS Neuroscience & Therapeutics|May 18, 2026
Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double-Blind Randomized Controlled TrialXuefei Jia, Wenbo Cao, Tianying Li, et al.Vaccine|June 27, 2024
Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographicFei Jin, Lei Zhu, Yunpeng Wang, et al.International Journal of Biological Sciences|August 11, 2023
Intergenic CircRNA Circ_0007379 Inhibits Colorectal Cancer Progression by Modulating miR-320a Biogenesis in a KSRP-Dependent MannerFei Long, Liang Li, Canbin Xie, et al.Vaccine|February 16, 2024
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trialFei Jin, Yuanzheng Qiu, Zhiwei Wu, et al.Pageof 34